Brainstorm Cell TherapeuticsBCLI
13F holders, Q2 2025 (June 30)34holders +2
7new positions
5sold out
$0.67avg. 13F price*
At the end of Q2 2025, 34 institutions reported holding Brainstorm Cell Therapeutics (BCLI) in their 13F filings, up 2 from Q1 2025. 7 opened new positions and 5 sold out. The largest holders were Geode Capital Management, LLC ($61K), Vanguard Group Inc. ($31K) and Gunderson Capital Management LLC ($29K).
- Company
- Brainstorm Cell Therapeutics
- CUSIP
- 10501E300
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $75K |
| Exits | 5 | $891K |
All 13F filers, Q1 2025 → Q2 2025: 80,711 shares bought and 710,957 shares sold, net −630,246 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| Geode Capital Management, LLC | 0.00% | Reduce -6.2% | 54,582 | $61K |
| Vanguard Group Inc. | 0.00% | No change | 27,724 | $31K |
| Gunderson Capital Management LLC | 0.01% | New | 25,950 | $29K |
| BlackRock, Inc. | 0.00% | No change | 25,172 | $28K |
| Liberty Wealth Management LLC | 0.00% | No change | 22,666 | $25K |
| Weaver Consulting Group | 0.00% | No change | 15,623 | $17K |
| UBS Group AG | 0.00% | Add +4793.3% | 12,380 | $14K |
| Traynor Capital Management, Inc. | 0.00% | New | 11,000 | $12K |
| LPL Financial LLC | 0.00% | New | 10,698 | $12K |
| Almanack Investment Partners, LLC. | 0.00% | New | 10,000 | $11K |
| Morgan Stanley | 0.00% | Add +33.8% | 5,803 | $6K |
| Raymond James Financial Inc. | 0.00% | New | 5,158 | $6K |
| Harbour Investments, Inc. | 0.00% | New | 3,559 | $4K |
| Osaic Holdings, Inc. | 0.00% | Add +3.8% | 1,785 | $2K |
| Wells Fargo & Company | 0.00% | No change | 1,338 | $1K |
| Citigroup Inc. | 0.00% | New | 663 | $743 |
| Activest Wealth Management | 0.00% | No change | 334 | $374 |
| Bangor Savings Bank | 0.00% | No change | 266 | $298 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -0.9% | 218 | $244 |
| Jones Financial Companies LLLP | 0.00% | No change | 216 | $229 |
| Bank of America Corp. | 0.00% | Add +22.5% | 136 | $152 |
| VSM Wealth Advisory, LLC | 0.00% | No change | 120 | $134 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 113 | $127 |
| Clearstead Advisors, LLC | 0.00% | No change | 100 | $112 |
| Cranbrook Wealth Management, LLC | 0.00% | No change | 66 | $74 |
| St Germain D J Co. Inc. | 0.00% | No change | 33 | $37 |
| BNP Paribas Financial Markets | 0.00% | No change | 24 | $27 |
| CBIZ Investment Advisory Services, LLC | 0.00% | No change | 13 | $15 |
| Westside Investment Management, Inc. | 0.00% | No change | 12 | $14 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 10 | $11 |
| CoreCap Advisors, LLC | 0.00% | No change | 8 | $9 |
| FMR LLC | 0.00% | Reduce -97.4% | 6 | $7 |
| Bogart Wealth, LLC | 0.00% | No change | 2 | $2 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 157,009 | $0 |
"% of holder's portfolio" is BCLI's weight in each manager's 13F, not the share of Brainstorm Cell Therapeutics the manager owns.